Howe Jill Ann
- SEC CIK
- 0001892397
No open-market purchases or sales filed in the past year.
Current role at each company
- LCTX Lineage Cell Therapeutics, Inc.Chief Financial Officeras of Mar 6, 2026
- BIOR Biora Therapeutics, Inc.Directoras of Jun 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Howe Jill Ann as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LCTX Lineage Cell Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 (view filing) | Nov 26 | Same day | Howe Jill AnnChief Financial Officer | PPurchase | +15.0K | $0.59 | +$8.85K | +142.9%25.5K after | |
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | Howe Jill AnnChief Financial Officer | PPurchase | +10.5K | $0.89 | +$9.35K | New position10.5K after |